Your browser doesn't support javascript.
loading
Prenatal SAMe Treatment Induces Changes in Brain Monoamines and in the Expression of Genes Related to Monoamine Metabolism in a Mouse Model of Social Hierarchy and Depression, Probably via an Epigenetic Mechanism.
Becker, Maria; Abaev, Karin; Shmerkin, Elena; Weinstein-Fudim, Liza; Pinhasov, Albert; Ornoy, Asher.
Afiliação
  • Becker M; Department of Morphological Sciences and Teratology, Adelson School of Medicine, Ariel University, Ariel 4076414, Israel.
  • Abaev K; Department of Morphological Sciences and Teratology, Adelson School of Medicine, Ariel University, Ariel 4076414, Israel.
  • Shmerkin E; Department Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 4076414, Israel.
  • Weinstein-Fudim L; Department of Medical Neurobiology, Hebrew University Hadassah Medical School, Jerusalem 9112102, Israel.
  • Pinhasov A; Department of Morphological Sciences and Teratology, Adelson School of Medicine, Ariel University, Ariel 4076414, Israel.
  • Ornoy A; Department Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 4076414, Israel.
Int J Mol Sci ; 23(19)2022 Oct 07.
Article em En | MEDLINE | ID: mdl-36233200
Reduction in the levels of monoamines, such as serotonin and dopamine in the brain, were reported in patients and animals with depression. SAMe, a universal methyl donor and an epigenetic modulator, is successfully used as an adjunct treatment of depression. We previously found that prenatal treatment with SAMe of Submissive (Sub) mice that serve as a model for depression alleviated many of the behavioral depressive symptoms. In the present study, we treated pregnant Sub mice with 20 mg/kg of SAMe on days 12-15 of gestation and studied the levels of monoamines and the expression of genes related to monoamines metabolism in their prefrontal cortex (PFC) at the age of 3 months. The data were compared to normal saline-treated Sub mice that exhibit depressive-like symptoms. SAMe increased the levels of serotonin in the PFC of female Sub mice but not in males. The levels of 5-HIAA were not changed. SAMe increased the levels of dopamine and of DOPAC in males and females but increased the levels of HVA only in females. The levels of norepinephrine and its metabolite MHPG were unchanged. SAMe treatment changed the expression of several genes involved in the metabolism of these monoamines, also in a sex-related manner. The increase in several monoamines induced by SAMe in the PFC may explain the alleviation of depressive-like symptoms. Moreover, these changes in gene expression more than 3 months after treatment probably reflect the beneficial effects of SAMe as an epigenetic modulator in the treatment of depression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dopamina / Serotonina Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dopamina / Serotonina Idioma: En Ano de publicação: 2022 Tipo de documento: Article